Your browser doesn't support javascript.
loading
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.
Billings, Catherine G; Lewis, Robert; Hurdman, Judith A; Condliffe, Robin; Elliot, Charlie A; Thompson, A A Roger; Smith, Ian A; Austin, Matthew; Armstrong, Iain J; Hamilton, Neil; Charalampopoulos, Athanasios; Sabroe, Ian; Swift, Andrew J; Rothman, Alexander M; Wild, Jim M; Lawrie, Allan; Waterhouse, Judith C; Kiely, David G.
Afiliación
  • Billings CG; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Lewis R; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Hurdman JA; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK.
  • Condliffe R; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Elliot CA; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Thompson AAR; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Smith IA; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Austin M; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK.
  • Armstrong IJ; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Hamilton N; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Charalampopoulos A; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Sabroe I; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Swift AJ; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Rothman AM; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Wild JM; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK.
  • Lawrie A; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK.
  • Waterhouse JC; 3 Insigneo Institute for in silico Medicine, University of Sheffield, The Pam Liversidge Building, Sir Frederick Mappin Building, Sheffield, UK.
  • Kiely DG; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK.
Pulm Circ ; 9(2): 2045894019848649, 2019.
Article en En | MEDLINE | ID: mdl-30997865
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pulm Circ Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pulm Circ Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido